» Articles » PMID: 21404144

Actovegin®: a Biological Drug for More Than 5 Decades

Overview
Specialty General Medicine
Date 2011 Mar 16
PMID 21404144
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Actovegin(®) is a biological drug manufactured from a natural source: it is a calf blood hemodialysate. Its therapeutic benefits stem from a variety of pharmacodynamic actions that can be summarized to a common goal, i.e. the enhancement of cellular metabolism; this results from an insulin-like activity mediated by Inositol-phospho-oligosaccharides. Actovegin(®) results in beneficial effects in several pathophysiological clinical settings including malfunction of the blood circulation and trophic disturbances in the brain, impairment of peripheral blood circulation and associated diseases, dermal transplants and acute and chronic wounds. Here, we give an overview of the pharmacodynamic actions of calf-blood hemidialysate and its beneficial effects in a variety of clinical settings.

Citing Articles

The Physiological and Performance Effects of Actovegin during Maximal Cardiopulmonary Exercise Testing: A Randomized, Double-Blind, Placebo-Controlled Trial.

Milovanovic D, Radovanovic D, Zivkovic V, Srejovic I, Glisic M, Jakovljevic V Nutrients. 2024; 16(19).

PMID: 39408298 PMC: 11478799. DOI: 10.3390/nu16193332.


Actovegin in the management of patients after ischemic stroke: A systematic review.

la Fleur P, Baizhaxynova A, Reynen E, Kaunelis D, Galiyeva D PLoS One. 2022; 17(6):e0270497.

PMID: 35771887 PMC: 9246213. DOI: 10.1371/journal.pone.0270497.


Neuroprotective Effects of Deproteinized Calf Serum in Ischemic Stroke.

Li W, Guo A, Sun M, Wang J, Wang Q Front Neurol. 2021; 12:636494.

PMID: 34557139 PMC: 8453072. DOI: 10.3389/fneur.2021.636494.


Actovegin® reduces PMA-induced inflammation on human cells.

Reichl F, Hogg C, Liu F, Schwarz M, Teupser D, Hickel R Eur J Appl Physiol. 2020; 120(7):1671-1680.

PMID: 32447451 PMC: 8497287. DOI: 10.1007/s00421-020-04398-2.


Current Synthesis and Systematic Review of Main Effects of Calf Blood Deproteinized Medicine (Actovegin) in Ischemic Stroke.

Firan F, Romila A, Onose G Int J Mol Sci. 2020; 21(9).

PMID: 32365943 PMC: 7246744. DOI: 10.3390/ijms21093181.


References
1.
De Groot H, Brecht M, Machicao F . Evidence for a factor protective against hypoxic liver parenchymal cell injury in a protein-free blood extract. Res Commun Chem Pathol Pharmacol. 1990; 68(1):125-8. View

2.
Sigdestad C, Doak K, Grdina D . Differential protection of radiation-induced DNA single-strand breaks and cell survival by solcoseryl. Experientia. 1988; 44(8):707-8. DOI: 10.1007/BF01941036. View

3.
Lanner G, Argyropoulos . [Pharmacological effect of Solcoseryl on the metabolism of the brain. Animal experiments and clinical research]. Wien Med Wochenschr. 1975; 125(47):681-5. View

4.
Brecht M, De Groot H . Protection from hypoxic injury in cultured hepatocytes by glycine, alanine, and serine. Amino Acids. 2013; 6(1):25-35. DOI: 10.1007/BF00808120. View

5.
Saletu B, Grunberger J, Linzmayer L, Anderer P, Semlitsch H . EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials. Neuropsychobiology. 1990; 24(3):135-48. DOI: 10.1159/000119476. View